Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ed Schuuring

Showing results (11-20 of 210) with videos related to

Pageof 21
Sort By:
Immunogenetics|May 21, 2003
Mutations in the HLA class II genes leading to loss of expression of HLA-DR and HLA-DQ in diffuse large B-cell lymphomaEkaterina S Jordanova, Katja Philippo, Marius J Giphart, et al.
International Journal of Cancer|December 10, 2002
Beta2-microglobulin aberrations in diffuse large B-cell lymphoma of the testis and the central nervous systemEkaterina S Jordanova, Sietske A Riemersma, Katja Philippo, et al.
Diagnostics (Basel, Switzerland)|August 10, 2024
Utility and Micro-Costing Framework for <i>TERT</i> Promoter Mutation Analysis in Melanocytic Lesions of Uncertain Malignant Potential: A Retrospective Study in Dutch Local Clinical PracticeLeire Barrutia, Ed Schuuring, Emõke Rácz, et al.
Haematologica|July 26, 2007
From brain to testis: immune escape and clonal selection in a B cell lymphoma with selective outgrowth in two immune sanctuaries [correction of sanctuariesy]Marije Booman, Jenny Douwes, Marie-Cecile Legdeur, et al.
Breast Cancer Research : BCR|November 11, 2005
Cortactin overexpression results in sustained epidermal growth factor receptor signaling by preventing ligand-induced receptor degradation in human carcinoma cellsAgnes G S H van Rossum, Johan Gibcus, Jacqueline van der Wal, et al.
Virchows Archiv : an International Journal of Pathology|August 8, 2020
"The leading role of pathology in assessing the somatic molecular alterations of cancer: Position Paper of the European Society of Pathology": letter to the EditorWinand N M Dinjens, Marjolijn J L Ligtenberg, Tom van Wezel, et al.
Genes, Chromosomes & Cancer|August 31, 2002
Hemizygous deletions in the HLA region account for loss of heterozygosity in the majority of diffuse large B-cell lymphomas of the testis and the central nervous systemEkaterina S Jordanova, Sietske A Riemersma, Katja Philippo, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|May 22, 2026
PAX1 and ZNF582 methylation as a triage strategy in cytological and hrHPV-positive scrapings in both Chinese and Dutch cohortsNa Li, Yuanjing Hu, Ate G J van der Zee, et al.
Genes, Chromosomes & Cancer|December 31, 2005
H2AX is not affected in mantle cell lymphoma with 11q23 deletionJeroen E J Guikema, Rinny W de Boer-Bergsma, Karine Akkermans, et al.
Clinical & Translational Immunology|June 18, 2020
Immune microenvironment composition in non-small cell lung cancer and its association with survivalMenno Tamminga, Thijo Jeroen N Hiltermann, Ed Schuuring, et al.
Pageof 21

Showing results (11-20 of 210) with videos related to

Sort By:
Pageof 21
Immunogenetics|May 21, 2003
Mutations in the HLA class II genes leading to loss of expression of HLA-DR and HLA-DQ in diffuse large B-cell lymphomaEkaterina S Jordanova, Katja Philippo, Marius J Giphart, et al.
International Journal of Cancer|December 10, 2002
Beta2-microglobulin aberrations in diffuse large B-cell lymphoma of the testis and the central nervous systemEkaterina S Jordanova, Sietske A Riemersma, Katja Philippo, et al.
Diagnostics (Basel, Switzerland)|August 10, 2024
Utility and Micro-Costing Framework for <i>TERT</i> Promoter Mutation Analysis in Melanocytic Lesions of Uncertain Malignant Potential: A Retrospective Study in Dutch Local Clinical PracticeLeire Barrutia, Ed Schuuring, Emõke Rácz, et al.
Haematologica|July 26, 2007
From brain to testis: immune escape and clonal selection in a B cell lymphoma with selective outgrowth in two immune sanctuaries [correction of sanctuariesy]Marije Booman, Jenny Douwes, Marie-Cecile Legdeur, et al.
Breast Cancer Research : BCR|November 11, 2005
Cortactin overexpression results in sustained epidermal growth factor receptor signaling by preventing ligand-induced receptor degradation in human carcinoma cellsAgnes G S H van Rossum, Johan Gibcus, Jacqueline van der Wal, et al.
Virchows Archiv : an International Journal of Pathology|August 8, 2020
"The leading role of pathology in assessing the somatic molecular alterations of cancer: Position Paper of the European Society of Pathology": letter to the EditorWinand N M Dinjens, Marjolijn J L Ligtenberg, Tom van Wezel, et al.
Genes, Chromosomes & Cancer|August 31, 2002
Hemizygous deletions in the HLA region account for loss of heterozygosity in the majority of diffuse large B-cell lymphomas of the testis and the central nervous systemEkaterina S Jordanova, Sietske A Riemersma, Katja Philippo, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|May 22, 2026
PAX1 and ZNF582 methylation as a triage strategy in cytological and hrHPV-positive scrapings in both Chinese and Dutch cohortsNa Li, Yuanjing Hu, Ate G J van der Zee, et al.
Genes, Chromosomes & Cancer|December 31, 2005
H2AX is not affected in mantle cell lymphoma with 11q23 deletionJeroen E J Guikema, Rinny W de Boer-Bergsma, Karine Akkermans, et al.
Clinical & Translational Immunology|June 18, 2020
Immune microenvironment composition in non-small cell lung cancer and its association with survivalMenno Tamminga, Thijo Jeroen N Hiltermann, Ed Schuuring, et al.
Pageof 21